Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,033 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy.
Terai S, Tanimoto H, Maeda M, Zaitsu J, Hisanaga T, Iwamoto T, Fujisawa K, Mizunaga Y, Matsumoto T, Urata Y, Marumoto Y, Hidaka I, Ishikawa T, Yokoyama Y, Aoyama K, Tsuchiya M, Takami T, Omori K, Yamamoto N, Segawa M, Uchida K, Yamasaki T, Okita K, Sakaida I. Terai S, et al. Among authors: iwamoto t. J Gastroenterol. 2012 May;47(5):491-7. doi: 10.1007/s00535-012-0580-5. Epub 2012 Apr 5. J Gastroenterol. 2012. PMID: 22488349 Review.
Effect of transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma.
Yamasaki T, Saeki I, Harima Y, Zaitsu J, Maeda M, Tanimoto H, Iwamoto T, Hidaka I, Urata Y, Ishikawa T, Takami T, Yamaguchi Y, Uchida K, Terai S, Sakaida I. Yamasaki T, et al. Among authors: iwamoto t. J Gastroenterol. 2012 Jun;47(6):715-22. doi: 10.1007/s00535-012-0537-8. Epub 2012 Feb 11. J Gastroenterol. 2012. PMID: 22322658 Clinical Trial.
Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells.
Terai S, Takami T, Yamamoto N, Fujisawa K, Ishikawa T, Urata Y, Tanimoto H, Iwamoto T, Mizunaga Y, Matsuda T, Oono T, Marumoto M, Burganova G, Fernando Quintanilha L, Hidaka I, Marumoto Y, Saeki I, Uchida K, Yamasaki T, Tani K, Taura Y, Fujii Y, Nishina H, Okita K, Sakaida I. Terai S, et al. Among authors: iwamoto t. Tissue Eng Part B Rev. 2014 Jun;20(3):206-10. doi: 10.1089/ten.TEB.2013.0527. Epub 2014 Mar 7. Tissue Eng Part B Rev. 2014. PMID: 24450831 Review.
Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma.
Saeki I, Yamamoto N, Yamasaki T, Takami T, Maeda M, Fujisawa K, Iwamoto T, Matsumoto T, Hidaka I, Ishikawa T, Uchida K, Tani K, Sakaida I. Saeki I, et al. Among authors: iwamoto t. World J Gastroenterol. 2016 Oct 28;22(40):8967-8977. doi: 10.3748/wjg.v22.i40.8967. World J Gastroenterol. 2016. PMID: 27833388 Free PMC article. Clinical Trial.
Splenic non-infarction volume determines a clinically significant hepatic venous pressure gradient response to partial splenic embolization in patients with cirrhosis and hypersplenism.
Ishikawa T, Sasaki R, Nishimura T, Matsuda T, Iwamoto T, Saeki I, Hidaka I, Takami T, Sakaida I. Ishikawa T, et al. Among authors: iwamoto t. J Gastroenterol. 2021 Apr;56(4):382-394. doi: 10.1007/s00535-021-01762-7. Epub 2021 Feb 24. J Gastroenterol. 2021. PMID: 33629147
2,033 results